Antisense Therapeutics: A devastating disease with no cure but hope is on the horizon 

Listen to ASX-listed Antisense Therapeutics Managing Director Mark Diamond talk to Matt Birney on the Bulls N’ Bears Report about Antisense’s clever developing drug technology that is slated to tackle a medicinal market expected to be worth US$10b by 2030.

Antisense Therapeutics: A devastating disease with no cure but hope is on the horizon 
Listen to ASX-listed Antisense Therapeutics Managing Director Mark Diamond talk to Matt Birney on the Bulls N&rsquo; Bears Report about Antisense&rsquo;s clever developing drug technology that is slated to tackle a medicinal market expected to be worth US$10b by 2030.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement